Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts

American Journal of Pathology

Volumn 175, Issue 6, 2009, Pages 2392-2405

  Fickert, Peter ^a   Fuchsbichler, Andrea ^a   Moustafa, Tarek ^a   Wagner, Martin ^a   Zollner, Gernot ^a   Halilbasic, Emina ^a   Stöger, Ulrike ^a   Arrese, Marco ^b   Pizarro, Margarita ^b   Solís, Nancy ^b   Carrasco, Gonzalo ^b   Caligiuri, Alessandra ^c   Sombetzki, Martina ^d   Reisinger, Emil ^d   Tsybrovskyy, Oleksiy ^a   Zatloukal, Kurt ^e   Denk, Helmut ^c   Jaeschke, Hartmut ^e   Pinzani, Massimo ^c   Trauner, Michael ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Research Center   (Italy)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; CARBON TETRACHLORIDE; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID X RECEPTOR; PREGNANE X RECEPTOR; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; FEEDING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTOXICATION; KNOCKOUT MOUSE; LIVER FIBROSIS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; STELLATE CELL; WILD TYPE;

EID: 73549089485     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090114     Document Type: Article

References (42)

1. Zollner G, Marschall HU, Wagner M, Trauner M: Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 2006, 3:231-251
2. Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y: FXR, a multipurpose nuclear receptor. Trends Biochem Sci 2006, 31:572-580
3. Modica S, Moschetta A: Nuclear bile acid receptor FXR as pharmacological target: are we there yet? FEBS Lett 2006, 580:5492-5499
4. Chen F, Ananthanarayanan M, Emre S, Neimark E, Bull LN, Knisely AS, Strautnieks SS, Thompson RJ, Magid MS, Gordon R, Balasubramanian N, Suchy FJ, Shneider BL: Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004, 126:756-764
5. Kovacs P, Kress R, Rocha J, Kurtz U, Miquel JF, Nervi F, Mendez-Sanchez N, Uribe M, Bock HH, Schirin-Sokhan R, Stumvoll M, Mossner J, Lammert F, Wittenburg H: Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 2008, 48:116-124
6. Zollner G, Wagner M, Fickert P, Silbert D, Gumhold J, Zatloukal K, Denk H, Trauner M: Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int 2007, 27:920-929
7. Van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J, Shevchuk V, Moore GE, Lammert F, Glantz AG, Mattsson LA, Whittaker J, Parker MG, White R, Williamson C: Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007, 133:507-516
8. Trauner M, Fickert P, Wagner M: MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 2007, 27:77-98
9. Wang L, Dong H, Soroka CJ, Wei N, Boyer JL, Hochstrasser M: Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II. Hepatology 2008, 48:1558-1569
10. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet 1998, 20:233-238
11. Thompson R, Strautnieks S: BSEP: function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001, 21:545-550
12. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744
13. Zollner G, Fickert P, Fuchsbichler A, Silbert D, Wagner M, Arbeiter S, Gonzalez FJ, Marschall HU, Zatloukal K, Denk H, Trauner M: Role of nuclear bile acid receptor. FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney, and intestine J Hepatol 2003, 39:480-488
14. Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O, Zatloukal K, Guo GL, Schuetz JD, Gonzalez FJ, Marschall HU, Denk H, Trauner M: Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003, 125:825-838
15. Stedman C, Liddle C, Coulter S, Sonoda J, Alvarez JG, Evans RM, Downes M: Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci USA 2006, 103:11323-11328
16. Marschall HU, Wagner M, Bodin K, Zollner G, Fickert P, Gumhold J, Silbert D, Fuchsbichler A, Sjovall J, Trauner M: Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 2006, 47:582-592
17. van Erpecum KJ, Wang DQ, Moschetta A, Ferri D, Svelto M, Portincasa P, Hendrickx JJ, Schipper M, Calamita G: Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 2006, 47:32-41
18. Moschetta A, Bookout AL, Mangelsdorf DJ: Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004, 10:1352-1358
19. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD: Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312:233-236
20. Honjo Y, Sasaki S, Kobayashi Y, Misawa H, Nakamura H: 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. J Endocrinol 2006, 188:635-643
21. Jung D, Mangelsdorf DJ, Meyer UA: Pregnane X receptor is a target of farnesoid X receptor. J Biol Chem 2006, 281:19081-19091
22. Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinal CJ, Guo GL, Gonzalez FJ, Yamazoe Y: Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J BiolChem 2003, 278:17838-17844
23. Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pellicciari R, Morelli A: The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 2004, 127:1497-1512
24. Fiorucci S, Clerici C, Antonelli E, Orlandi S, Goodwin B, Sadeghpour BM, Sabatino G, Russo G, Castellani D, Willson TM, Pruzanski M, Pellicciari R, Morelli A: Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J Pharmacol Exp Ther 2005, 313:604-612
25. Jiang T, Wang XX, Scherzer P, Wilson P, Tallman J, Takahashi H, Li J, Iwahashi M, Sutherland E, Arend L, Levi M: Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 2007, 56:2485-2493
26. Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA: Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra-and extrahepatic cholestasis. J Clin Invest 2003, 112:1678-1687
27. Eloranta JJ, Kullak-Ublick GA: The role of FXR in disorders of bile acid homeostasis. Physiology (Bethesda) 2008, 23:286-295
28. Wang YD, Chen WD, Moore DD, Huang W: FXR: a metabolic regulator and cell protector. Cell Res 2008, 18:1087-1095
29. Wang YD, Chen WD, Huang W: FXR, a target for different diseases. Histol Histopathol 2008, 23:621-627
30. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B: Role of bile acids and bile Acid receptors in metabolic regulation. Physiol Rev 2009, 89:147-191
31. Dunn MA, Rojkind M, Warren KS, Hait PK, Rifas L, Seifter S: Liver collagen synthesis in murine schistosomiasis. J Clin Invest 1977, 59:666-674
32. Wyler DJ, Wahl SM, Wahl LM: Hepatic fibrosis in schistosomiasis: egg granulomas secrete fibroblast stimulating factor in vitro. Science 1978, 202:438-440
33. Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H: Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol 2002, 161:2019-2026
34. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL: The rat canalicular conjugate export pump (ABCC2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997, 113:255-264
35. Zollner G, Wagner M, Moustafa T, Fickert P, Silbert D, Gumhold J, Fuchsbichler A, Halilbasic E, Denk H, Marschall HU, Trauner M: Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 2006, 290:G923-G932
36. Wagner M, Zollner G, Fickert P, Gumhold J, Silbert D, Fuchsbichler A, Gujral JS, Zatloukal K, Denk H, Jaeschke H, Trauner M: Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress. Drug Metab Dispos 2007, 35:1694-1699
37. Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H, Trauner M: A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007, 171:525-536
38. Uchio K, Tuchweber B, Manabe N, Gabbiani G, Rosenbaum J, Desmouliere A: Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab Invest 2002, 82:619-628
39. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, Gentilini P: Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000, 119:466-478
40. Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W: Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 2008, 48:1632-1643
41. Krishnamurthy PC, Du G, Fukuda Y, Sun D, Sampath J, Mercer KE, Wang J, Sosa-Pineda B, Murti KG, Schuetz JD: Identification of a mammalian mitochondrial porphyrin transporter. Nature 2006, 443:586-589
42. Gascon-Barre M, Demers C, Mirshahi A, Neron S, Zalzal S, Nanci A: The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 2003, 37:1034-1042